Zenotech Laboratories

Zenotech Laboratories Equity

The The Equity of Zenotech Laboratories (532039.BO) as of Oct 9, 2026 is 951.21 M INR. In the previous year, The Equity was 961.31 M INR — a change of -1.05% (lower).

Equity

951.21 MINR

YoY

-1.05%

Last updated:

In 2026, Zenotech Laboratories's equity was 951.21 M INR, a -1.05% increase from the 961.31 M INR equity in the previous year.

The Zenotech Laboratories Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
388.98 M INR
Jan 1, 2020
496.29 M INR
Jan 1, 2021
484.08 M INR
Jan 1, 2022
706.40 M INR
Jan 1, 2023
822.70 M INR
Jan 1, 2024
905.42 M INR
Jan 1, 2025
961.31 M INR
Jan 1, 2026
951.21 M INR
The Zenotech Laboratories Equity history
YEAREquityYoY
951.21 MINR-1.05%
961.31 MINR+6.17%
905.42 MINR+10.05%
822.70 MINR+16.46%
706.40 MINR+45.93%
484.08 MINR-2.46%
496.29 MINR+27.59%
388.98 MINR-7.42%
420.18 MINR-163.75%
-659.07 MINR+43.07%
-460.66 MINR+71.18%
-269.11 MINR+293.56%
-68.38 MINR—
Access this data via the Eulerpool API
Get Free API Key

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Zenotech Laboratories's Equity

Zenotech Laboratories's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Zenotech Laboratories's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Zenotech Laboratories's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Zenotech Laboratories's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Zenotech Laboratories’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Zenotech Laboratories stock

The Equity of Zenotech Laboratories is 951.21 M INR in 2026.

The Equity of Zenotech Laboratories changed from 961.31 M INR to 951.21 M INR, representing a -1.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Zenotech Laboratories historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Zenotech Laboratories

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Zenotech Laboratories